Analytical Data
-
Gene name
BH0637
- Application
-
Alternative Names
BH0637；
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9KF49
-
Expression Region
1-328aa
-
AA Sequence
MCEQKYRWTKKQIRQQLAVVRGEMAPTLVLKNATYLNSVRGKWLDANIWI YQDRIVYVGQDMPAKLDDETEVVDCGQQVIVPGYIEHHAHPFQLYNPHSF ANYAAAMGTTTLINDNLMFFLALEKKKALSMIESLDELPSSMYWWCRYDP QTEMNDEEGHFLNSKIKEWLEHPLVVQGGELTSWPKVITGDDGILHWMQE TRRLRKPIEGHFPGASEKTLTQMSLLGVTSDHEAMTGEEVIRRLDLGYMT SLRHSSIRSDLAKILREMKELGIDDFSRCMLTTDGSPPSFYEQGIMDRLI KIALDEGIPPKDAYGMATYYVARYYGLD
-
Molecular Weight
58 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The BH0637 recombinant protein has garnered significant interest in the field of molecular biology and biotechnology due to its potential applications in therapeutic development and industrial processes. It is derived from the bacterium Burkholderia cenocepacia, known for its ability to thrive in various environments, including those that are hostile to many organisms. Research into BH0637 has revealed its involvement in critical biological pathways, particularly those related to stress response and virulence factors in pathogenic strains. The protein's unique structure and functionality present opportunities for understanding its role in microbial pathogenesis, as well as its potential as a target for novel antimicrobial therapies. Furthermore, the recombinant production of BH0637 allows for the detailed study of its biochemical properties and interactions, paving the way for applications in drug design and synthetic biology. As the demand for innovative solutions to combat antibiotic resistance and emerging infectious diseases increases, the exploration of BH0637 and its mechanistic insights holds promise for contributing to advances in healthcare and biotechnology. Ongoing research aims to elucidate its specific functions and interactions within cellular systems, which may ultimately lead to new strategies for prevention and treatment of bacterial infections.
